Citation: | ZHANG Bin, CHEN Lei, JI Zhenxin, WU Meimei, LIU Changfang. Expression and significance of endothelial cell-derived extracellular vesicles in peripheral blood of patients with sepsis-induced cardiomyopathy[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 112-116, 121. DOI: 10.7619/jcmp.20243725 |
To investigate the expression characteristics and clinical significance of endothelial cell-derived extracellular vesicles (EC-EVs) in the peripheral blood of patients with sepsis-induced cardiomyopathy (SIC).
A total of 143 sepsis patients were enrolled and divided into cardiomyopathy group (n=72) and non-cardiomyopathy group (n=71) based on occurrence of SIC. Peripheral blood samples were collected from patients in both groups upon admission for isolation and identification of EC-EVs. The number of EC-EVs, apoptosis, and the activity and expression levels of caspase-1 in EC-EVs were compared between the two groups. Spearman correlation analysis was used to assess the correlations of the number of EC-EVs, caspase-1 activity, and N-terminal pro-brain natriuretic peptide (NT-proBNP) with cardiac troponin Ⅰ (cTnⅠ). Multivariable Logistic regression analysis was conducted to explore the factors influencing the occurrence of SIC in sepsis patients. Receiver operating characteristic (ROC) curves were plotted to analyze the predictive value of the number of EC-EVs and caspase-1 activity for SIC.
EC-EVs with a diameter of approximately 100 nm, intact membrane structure, and expression of extracellular vesicles (EVs) marker molecules (CD9, CD63, CD81) were successfully isolated from samples in both groups. The cardiomyopathy group had significantly higher numbers of EC-EVs in peripheral blood, EC-EV apoptosis levels, caspase-1 activity, and protein expression levels compared to the non-cardiomyopathy group(P < 0.05). Spearman correlation analysis revealed positive correlations between the number of EC-EVs and NT-proBNP (r=0.603, 0.685, P < 0.001), and between caspase-1 activity and cTnI (r=0.474, 0.711, P < 0.001). Multivariable Logistic regression analysis showed that the number of EC-EVs, caspase-1 activity, NT-proBNP levels, and cTnI levels were all independent influencing factors for the occurrence of SIC in sepsis patients (P < 0.05). The ROC curves indicated that the areas under the curve for predicting SIC based on the number of EC-EVs and caspase-1 activity in peripheral blood were 0.721 and 0.858, respectively.
The number of EC-EVs and caspase-1 activity in EC-EVs in the peripheral blood of SIC patients are significantly increased, and are closely related to cardiac function and myocardial injury in sepsis patients. Thus, they have the potential to become biomarkers for predicting SIC.
[1] |
L'HEUREUX M, STERNBERG M, BRATH L, et al. Sepsis-induced cardiomyopathy: a comprehensive review[J]. Curr Cardiol Rep, 2020, 22(5): 35. doi: 10.1007/s11886-020-01277-2
|
[2] |
YE R Z, LIN Q Y, XIAO W K, et al. miR-150-5p in neutrophil-derived extracellular vesicles associated with sepsis-induced cardiomyopathy in septic patients[J]. Cell Death Discov, 2023, 9(1): 19. doi: 10.1038/s41420-023-01328-x
|
[3] |
HABIMANA R, CHOI I, CHO H J, et al. Sepsis-induced cardiac dysfunction: a review of pathophysiology[J]. Acute Crit Care, 2020, 35(2): 57-66. doi: 10.4266/acc.2020.00248
|
[4] |
HOLLENBERG S M, SINGER M. Pathophysiology of sepsis-induced cardiomyopathy[J]. Nat Rev Cardiol, 2021, 18(6): 424-434. doi: 10.1038/s41569-020-00492-2
|
[5] |
VAN NIEL G, CARTER D R F, CLAYTON A, et al. Challenges and directions in studying cell-cell communication by extracellular vesicles[J]. Nat Rev Mol Cell Biol, 2022, 23(5): 369-382. doi: 10.1038/s41580-022-00460-3
|
[6] |
MARGOLIS L, SADOVSKY Y. The biology of extracellular vesicles: the known unknowns[J]. PLoS Biol, 2019, 17(7): e3000363. doi: 10.1371/journal.pbio.3000363
|
[7] |
MARKI A, BUSCHER K, LORENZINI C, et al. Elongated neutrophil-derived structures are blood-borne microparticles formed by rolling neutrophils during sepsis[J]. J Exp Med, 2021, 218(3): e20200551. doi: 10.1084/jem.20200551
|
[8] |
HE Z H, WANG H X, YUE L J. Endothelial progenitor cells-secreted extracellular vesicles containing microRNA-93-5p confer protection against sepsis-induced acute kidney injury via the KDM6B/H3K27me3/TNF-α axis[J]. Exp Cell Res, 2020, 395(2): 112173. doi: 10.1016/j.yexcr.2020.112173
|
[9] |
SONG J, FANG X, ZHOU K, et al. Sepsis-induced cardiac dysfunction and pathogenetic mechanisms (Review)[J]. Mol Med Rep, 2023, 28(6): 227. doi: 10.3892/mmr.2023.13114
|
[10] |
WANG R Z, XU Y R, FANG Y X, et al. Pathogenetic mechanisms of septic cardiomyopathy[J]. J Cell Physiol, 2022, 237(1): 49-58. doi: 10.1002/jcp.30527
|
[11] |
SONG M J, LEE S H, LEEM A Y, et al. Predictors and outcomes of sepsis-induced cardiomyopathy in critically ill patients[J]. Acute Crit Care, 2020, 35(2): 67-76. doi: 10.4266/acc.2020.00024
|
[12] |
BHAGWAN VALJEE R, MACKRAJ I, MOODLEY R, et al. Investigation of exosomal tetraspanin profile in sepsis patients as a promising diagnostic biomarker[J]. Biomarkers, 2024, 29(2): 78-89. doi: 10.1080/1354750X.2024.2319296
|
[13] |
ZHU Y Y, ZHU J, TIAN X H, et al. Circulating endothelial progenitor cells from septic patients are associated with different infectious organisms[J]. Ann Palliat Med, 2021, 10(1): 549-559.
|
[14] |
REFAIE M M M, EL-HUSSIENY M, BAYOUMI A M A, et al. Sacubitril/valsartan alleviates sepsis-induced myocardial injury in rats via dual angiotensin receptor-neprilysin inhibition and modulation of inflammasome/caspase 1/IL1β pathway[J]. Eur J Pharmacol, 2024, 979: 176834.
|
[15] |
BALL D P, TAABAZUING C Y, GRISWOLD A R, et al. Caspase-1 interdomain linker cleavage is required for pyroptosis[J]. Life Sci Alliance, 2020, 3(3): e202000664.
|
[16] |
NASERI A, AKYUZ E, TURGUT K, et al. Sepsis-induced cardiomyopathy in animals: from experimental studies to echocardiography-based clinical research[J]. Can Vet J, 2023, 64(9): 871-877.
|
[17] |
CARBONE F, LIBERALE L, PREDA A, et al. Septic cardiomyopathy: from pathophysiology to the clinical setting[J]. Cells, 2022, 11(18): 2833.
|
[18] |
LAURA FRANCÉS J, PAGIATAKIS C, DI MAURO V, et al. Therapeutic potential of EVs: targeting cardiovascular diseases[J]. Biomedicines, 2023, 11(7): 1907.
|